TRACON PHARMACEUTICALS INC's ticker is TCON and the CUSIP is 89237H209.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,852 | -39.0% | 10,407 | -0.3% | 0.00% | – |
| Q2 2023 | $3,037 | +50516.7% | 10,436 | +211.8% | 0.00% | – |
| Q1 2023 | $6 | -53.8% | 3,347 | -60.7% | 0.00% | -100.0% |
| Q4 2022 | $13 | -99.9% | 8,517 | +24.6% | 0.00% | – |
| Q3 2022 | $11,000 | +266.7% | 6,837 | +322.0% | 0.00% | – |
| Q2 2022 | $3,000 | +200.0% | 1,620 | +518.3% | 0.00% | – |
| Q1 2022 | $1,000 | -50.0% | 262 | -41.1% | 0.00% | – |
| Q3 2021 | $2,000 | -95.6% | 445 | -91.9% | 0.00% | -100.0% |
| Q1 2021 | $45,000 | -66.7% | 5,486 | -52.6% | 0.00% | -75.0% |
| Q4 2020 | $135,000 | +1025.0% | 11,564 | +418.8% | 0.00% | – |
| Q3 2020 | $12,000 | – | 2,229 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,518,371 | $16,344,000 | 2.72% |
| Ikarian Capital, LLC | 2,716,840 | $17,631,000 | 1.42% |
| Telemetry Investments, L.L.C. | 40,000 | $260,000 | 0.36% |
| ACT CAPITAL MANAGEMENT, LLC | 28,500 | $185,000 | 0.10% |
| Vigilare Wealth Management | 17,000 | $110,000 | 0.07% |
| X-Square Capital, LLC | 20,973 | $136,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 294,031 | $1,908,000 | 0.06% |
| Johnson & Johnson Innovation - JJDC, Inc. | 84,003 | $545,000 | 0.06% |
| NEA Management Company, LLC | 346,718 | $2,250,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 36,370 | $236,000 | 0.03% |